The current literature on the functional role of Oct4 in epithelial ovarian cancer is relatively sparse, with the transcription factor primarily being used as a marker to detect CSC-like cells in primary ovarian tumours and patient ascites samples [50]. This evidence concerns the gene POU5F1 and ovarian neoplasm.